Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.
BuchGebunden
411 Seiten
Englisch
Springererschienen am30.03.20242024
197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too.mehr
Verfügbare Formate
BuchGebunden
EUR171,19
E-BookPDF1 - PDF WatermarkE-Book
EUR160,49

Produkt

Klappentext197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too.
Details
ISBN/GTIN978-3-031-52863-7
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2024
Erscheinungsdatum30.03.2024
Auflage2024
Seiten411 Seiten
SpracheEnglisch
Gewicht819 g
IllustrationenX, 411 p. 70 illus.
Artikel-Nr.55811702
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Part I. Nanoparticles and other Advanced Technologies.-  Knowledge-based design of multi-functional polymer-based nanoparticles.-  Stimuli-responsive non-viral nanoparticles for gene delivery.- Sustainability in drug and nano-particle processing.- Advanced formulation approaches for proteins.- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids.- Advances in vaccine delivery enhancers - small molecules and nanomaterials.- Biodegradable long acting injectables: Platform technology and industrial challenges.- Part II. Visualization Technologies.- Visualization of Nano-carriers and Drugs in Cells and Tissue.- Characterization of drug delivery systems by transmission electron microscopy.-  Part III. Target Specific Delivery.- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders.- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints.- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism.- Molecular therapeutics for pulmonary diseases - the need for drug targeting.- Delivery of mitochondrial RNA.- Part IV. Concerted Actions - Thinking the Drug from the Beginning.- ATMP formulations and delivery.- Preclinical testing and approval of ATMP.- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases.mehr

Autor